Conclusions: Prevalence of obesity is increasing, and use of GLP-1 RAs as the preferred antiobesity medication has increased ...
Ever wonder why your firm’s AI initiatives don’t seem to be going anywhere? Your firm might not have the right people, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results